Clinical trial
The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship
NCT02806128 is registered in ClinicalTrials.gov with Huisheng Chen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship
- Lead sponsor
- Huisheng Chen
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2016
- Completion date
- Not reported
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.